Technology Offerings

Alexander Disease – Modulators of the unconventional protein secretion in AxD

Alexander Disease (AxD) is a rare fatal neurodegenerative disorder that is attributed to mutations in glial fubrillary acidic protein (GFAP). Clinically, AxD is considered a type of leukoencephalopathy sometimes characterized by demyelination of the central nervous system (CNS) and the formation of GFAP-containing Rosenthal fibers in astrocytes.

While it has been shown that GFAP mutations cause AxD, the exact pathomechanism is still unknown and there is still no accepted line of treatment.

The present invention provides a new approach for AxD therapy based on the newly indentified role of GFAP in the unconventional secretory pathway (USP).

Further information: PDF

PROvendis GmbH
Phone: +49 (0)208/94105 10

Contact
Dipl.-Ing. Alfred Schillert

As Germany's association of technology- and patenttransfer agencies TechnologieAllianz e.V. is offering businesses access to the entire range of innovative research results of almost all German universities and numerous non-university research institutions. More than 2000 technology offers of 14 branches are beeing made accessable to businesses in order to assure your advance on the market. At www.technologieallianz.de a free, fast and non-bureaucratic access to all further offers of the German research landscape is offered to our members aiming to sucessfully transfer technologies.

Comments (0)

Write a comment